1197400002: Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\...
• \Nucleotidyltransferase inhibitor-containing product\Integrase strand transfer inhibitor-containing product\Dolutegravir-containing product\...
• \Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir and lamivudine and tenofovir only product\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Dolutegravir-containing product in oral dose form\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Reverse transcriptase inhibitor-containing product\Tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Reverse transcriptase inhibitor-containing product\Tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir and lamivudine and tenofovir only product\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Reverse transcriptase inhibitor-containing product\Tenofovir-containing product\Tenofovir-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Reverse transcriptase inhibitor-containing product\Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Reverse transcriptase inhibitor-containing product\Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir and lamivudine and tenofovir only product\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Reverse transcriptase inhibitor-containing product\Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Reverse transcriptase inhibitor-containing product\Lamivudine-containing product\Lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir and lamivudine and tenofovir only product\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Tenofovir-containing product\Tenofovir-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Pyrimidine-containing product\Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Pyrimidine-containing product\Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir and lamivudine and tenofovir only product\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Pyrimidine-containing product\Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Pyrimidine-containing product\Lamivudine-containing product\Lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Dolutegravir-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Dolutegravir-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir and lamivudine and tenofovir only product\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Dolutegravir-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Dolutegravir-containing product\Dolutegravir-containing product in oral dose form\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nucleoside analogue-containing product\Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nucleoside analogue-containing product\Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir and lamivudine and tenofovir only product\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nucleoside analogue-containing product\Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by structure\Nucleoside analogue-containing product\Lamivudine-containing product\Lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Medicinal product categorised by therapeutic role\Antiviral agent\Antiretroviral agent\...
• \Dolutegravir-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Dolutegravir-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir and lamivudine and tenofovir only product\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Dolutegravir-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Dolutegravir-containing product\Dolutegravir-containing product in oral dose form\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir and lamivudine and tenofovir only product\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Tenofovir-containing product\Tenofovir-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine- and tenofovir-containing product\Dolutegravir and lamivudine and tenofovir only product\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Lamivudine-containing product\Dolutegravir- and lamivudine-containing product\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Lamivudine-containing product\Lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Product manufactured as oral dose form\Dolutegravir-containing product in oral dose form\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Product manufactured as oral dose form\Lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
• \Product manufactured as oral dose form\Tenofovir-containing product in oral dose form\Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form\Dolutegravir and lamivudine and tenofovir only product in oral dose form\Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet

Status: current, Defined. Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4696205017	Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
4696560013	Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet	en	Synonym	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start